An uncontrolled supplement study reported improved anxiety scores over twenty-eight days. Its concluding comparison with benzodiazepines went beyond a randomized head-to-head safety test.
The observed change
Clinicians followed patients with adjustment disorder and anxiety who received a preparation combining fish-derived peptides, magnesium, and vitamin B6. Mean anxiety scores declined, and some participants met a prespecified response threshold.
The study also described global improvement and reported tolerability during its short course.
The missing comparator
Without randomized benzodiazepine and placebo groups, improvement could reflect time, expectations, clinical attention, regression to the mean, or the preparation itself. The design cannot separate those explanations fully.
A short uncontrolled tolerability report cannot establish comparative dependence, withdrawal, uncommon harms, or long-term benefit. The paper supplies preliminary observations about a specific formulation. It does not prove that the supplement is an equally effective or safer replacement for a prescribed benzodiazepine, or establish that every person with anxiety should change treatment.
Source paper
Original analysis of the supplied journal article, identified as PMC9228954.
Leave a Reply